Paper220094
Penicillinase active sites: labelling of serine-44 in beta-lactamase I by 6beta-bromopenicillanic acid.
Knott-Hunziker V and 3 others. FEBS Lett, 1979. Cited by 127 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Penicillinase active sites: labelling of serine-44 in beta-lactamase I by 6beta-bromopenicillanic acid. Papers, record 220094. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/220094
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Penicillinase active sites: labelling of serine-44 in beta-lactamase I by 6beta-bromopenicillanic acid.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Penicillanic Acid | Major topic |
| Penicillinase | Major topic |
| beta-Lactamases | Major topic |
| Affinity Labels | |
| Binding Sites | |
| Peptide Fragments | |
| Serine | |
| Spectrophotometry, Ultraviolet |
Source PubMed
Cited by40
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 127 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37175597 | Antimicrobial Resistance in Romania: Updates on Gram-Negative ESCAPE Pathogens in the Clinical, Veterinary, and Aquatic Sectors. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37175597 | PubMed |
| 35768448 | Detection by metagenomic functional analysis and improvement by experimental evolution of β-lactams resistance genes present in oil contaminated soils. | Sci Rep | 2022 | https://conductscience.org/library/papers/35768448 | PubMed |
| 33198306 | Emerging Strategies to Combat β-Lactamase Producing ESKAPE Pathogens. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33198306 | PubMed |
| 32903880 | Genotypic to Phenotypic Resistance Discrepancies Identified Involving β-Lactamase Genes, blaKPC, blaIMP, blaNDM-1, and blaVIM in Uropathogenic Klebsiella pneumoniae. | Infect Drug Resist | 2020 | https://conductscience.org/library/papers/32903880 | PubMed |
| 30061284 | Past and Present Perspectives on β-Lactamases. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/30061284 | PubMed |
| 24272608 | The Molecular Basis of β-Lactamase Catalysis and Inhibition. | Pharm Res | 1985 | https://conductscience.org/library/papers/24272608 | PubMed |
| 20421396 | Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase. | Antimicrob Agents Chemother | 2010 | https://conductscience.org/library/papers/20421396 | PubMed |
| 20394454 | Current challenges in antimicrobial chemotherapy: focus on ß-lactamase inhibition. | Drugs | 2010 | https://conductscience.org/library/papers/20394454 | PubMed |
| 19919161 | Structural basis of the inhibition of class A beta-lactamases and penicillin-binding proteins by 6-beta-iodopenicillanate. | J Am Chem Soc | 2009 | https://conductscience.org/library/papers/19919161 | PubMed |
| 12456788 | Biochemistry and comparative genomics of SxxK superfamily acyltransferases offer a clue to the mycobacterial paradox: presence of penicillin-susceptible target proteins versus lack of efficiency of penicillin as therapeutic agent. | Microbiol Mol Biol Rev | 2002 | https://conductscience.org/library/papers/12456788 | PubMed |
| 8240281 | Interactions between active-site-serine beta-lactamases and mechanism-based inactivators: a kinetic study and an overview. | Biochem J | 1993 | https://conductscience.org/library/papers/8240281 | PubMed |
| 7305936 | The penicillin-binding site in the exocellular DD-carboxypeptidase-transpeptidase of Actinomadura R39. | Biochem J | 1981 | https://conductscience.org/library/papers/7305936 | PubMed |
| 7035856 | Antibiotic resistance in pathogenic and producing bacteria, with special reference to beta-lactam antibiotics. | Microbiol Rev | 1981 | https://conductscience.org/library/papers/7035856 | PubMed |
| 6983070 | Oligonucleotide-directed mutagenesis as a general and powerful method for studies of protein function. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6983070 | PubMed |
| 6982680 | Interaction of azthreonam and related monobactams with beta-lactamases from gram-negative bacteria. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6982680 | PubMed |
| 6978132 | Interactions between non-classical beta-lactam compounds and the beta-lactamases of Actinomadura R39 and Streptomyces albus G. | Biochem J | 1981 | https://conductscience.org/library/papers/6978132 | PubMed |
| 6975618 | The exocellular beta-lactamase of Streptomyces albus G. Purification, properties and comparison with the exocellular DD-carboxypeptidase. | Biochem J | 1981 | https://conductscience.org/library/papers/6975618 | PubMed |
| 6818947 | The acyl-enzyme mechanism of beta-lactamase action. The evidence for class C Beta-lactamases. | Biochem J | 1982 | https://conductscience.org/library/papers/6818947 | PubMed |
| 6807285 | Active sites of beta-lactamases. The chromosomal beta-lactamases of Pseudomonas aeruginosa and Escherichia coli. | Biochem J | 1982 | https://conductscience.org/library/papers/6807285 | PubMed |
| 6795623 | ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of beta-lactamases of the penicillinase type. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/6795623 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/220094
GET https://conductscience.org/api/papers/v1/220094/cited_by?page=2